Global Patent Filing Strategies: Navigating Specification Requirements Across Jurisdictions

When an inventor develops a breakthrough technology, protecting it globally isn’t as simple as filing one application and waiting. Every major patent jurisdiction – from India to the United States to Europe – has its own set of rules for how an invention must be described, claimed, and disclosed. A specification that sails through the Indian Patent Office could run into serious objections at the European Patent Office, and vice versa. For anyone pursuing international patent protection, understanding these jurisdictional differences isn’t optional – it’s the foundation of a sound filing strategy.

What a patent specification actually does 🔗

A patent specification is far more than a technical document. It performs two simultaneous functions: it discloses the invention to the public in enough detail for others to reproduce it, and it defines the legal boundaries of the protection being claimed. Worldwide, a basic requirement for a valid patent is that its specification provide sufficient disclosure of the invention being claimed, ensuring that once the patent expires, the public can actually use the disclosed technology. Every jurisdiction accepts this principle – but each applies it differently in practice.

India: the requirement under Section 10 🔗

Section 10 of the Patents Act, 1970 is the governing provision for patent specifications in India. It sets out what both provisional and complete specifications must contain, and it draws a clear line between the two.

What a complete specification must include 🔗

Under Section 10 of the Indian Patents Act, a complete specification must fully and particularly describe the invention and its operation or use (Section 10(4)(a)), disclose the best method of performing the invention known to the applicant (Section 10(4)(b)), end with a claim or set of claims defining the scope of protection (Section 10(4)(c)), and include drawings where applicable (Section 10(4)(d)). The title of the invention should not ordinarily exceed 15 words and must sufficiently indicate the subject matter.

The abstract is a separate but mandatory component. It must contain a concise summary within 150 words, indicating the technical field, the problem addressed, and the solution provided by the invention. It may also reference the figure that best illustrates the invention.

Claims: clarity and definiteness 🔗

Section 10(5) of the Patents Act requires that claims be clear, succinct, and fairly based on the description. The Bombay High Court, in Press Metal Corporation Limited v. Noshir Sorabji Pochkhanawalla, held that a patentee has a duty to state clearly and distinctly the nature and limits of what is claimed. Vague or speculative terms – such as “approximately,” “strong,” or “a major part” – are not acceptable in Indian patent claims unless they are accompanied by definite values. An inadequate or ambiguous specification can lead to refusal or revocation under Section 64 of the Act.

Best mode and biological material 🔗

The best mode disclosure requirement under Indian law is explicit: the applicant must disclose the best known method for performing the invention. For inventions involving biological material that cannot be fully described in writing, the applicant must deposit that material with an international depository authority under the Budapest Treaty, and reference the deposit in the specification. India joined the Budapest Treaty in September 2001 for this purpose.

European Patent Convention: sufficiency and technical character 🔗

The European Patent Office operates under the European Patent Convention (EPC), which takes a distinctly technical approach to specification requirements.

Article 83: sufficiency of disclosure 🔗

Article 83 EPC requires that a European patent application disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art. Critically, this sufficiency requirement must be met as of the filing date – a deficiency cannot be cured later without running afoul of Article 123(2) EPC, which prohibits extending the subject matter beyond what was originally filed. Insufficient disclosure is both a ground of opposition and a ground for revocation.

Article 84: clarity of claims and support 🔗

Article 84 EPC requires that claims define the matter for which protection is sought, and that they be clear, concise, and supported by the description. The EPO’s approach to claims is notably stricter than the US approach: European examiners expect claims to track the literal language of the description, and terms like “about” – which imply indefinite boundaries – are generally not acceptable since they prevent a clear determination of the patent’s metes and bounds.

Rule 42: structural requirements for the description 🔗

Rule 42 of the EPC lays down the required structure of the description. It must specify the technical field, indicate the relevant background art, disclose the technical problem the invention addresses, describe at least one way of carrying out the invention (with examples and references to drawings where appropriate), and indicate how the invention is industrially applicable. The European approach requires the inventor to fully disclose the problem to be solved and the technical solution, favouring an expansive disclosure with at least one very detailed embodiment and actual experimental results – prophetic (predicted) examples are viewed negatively by EPO examiners.

USPTO: enablement, written description, and best mode 🔗

US patent law under 35 U.S.C. § 112 imposes a three-pronged disclosure requirement: enablement, written description, and best mode.

A two-step disclosure standard 🔗

The US employs a two-step process: one step focusing on what was actually invented (written description) and another focusing on what has been enabled for a person skilled in the art (enablement). Both must be satisfied. The goal is that a person of ordinary skill in the art can understand and reproduce the claimed invention without undue experimentation. Unlike the EPO, the USPTO does not require the background section – and many US practitioners deliberately omit or minimise it to avoid creating a “comparative roadmap” that an examiner might use in an obviousness analysis.

Prophetic examples and incorporation by reference 🔗

US practice permits two tools that are generally unavailable or disfavoured in other jurisdictions. First, the USPTO accepts prophetic examples – predicted results presented in the present tense – unlike jurisdictions that require actual experimental data. Second, US practice explicitly permits incorporation by reference, allowing complex disclosures to be built more efficiently by referencing other documents. Neither of these tools works the same way before the EPO.

PCT: drafting for global reach 🔗

The Patent Cooperation Treaty (PCT), administered by WIPO, allows a single international application to simultaneously seek patent protection in its 158 Contracting States. Filing under the PCT does not result in an “international patent” – it establishes a filing date in all designated states and defers national examination, giving applicants up to 30 months from the priority date to decide where to pursue protection.

The PCT specification structure 🔗

The PCT recommends that the description be organised under standard headings: Technical Field, Background Art, Disclosure of Invention, Brief Description of Drawings, Best Mode for Carrying Out the Invention, Industrial Applicability, and (where applicable) Sequence Listing. Since a PCT application forms the basis for national phase entries across multiple jurisdictions, the specification, claims, drawings, and other documents must comply with the formatting requirements prescribed under Rule 35 of the Patents Rules, 2003 when entering the Indian national phase, while also satisfying the requirements of each other designated jurisdiction.

Strategic drafting for PCT applications 🔗

Because a PCT specification becomes the foundation for examination in every national phase country, it must be drafted to satisfy the most stringent requirements anticipated across all target jurisdictions. In practice, this means including comprehensive technical details and multiple examples covering various embodiments, anticipating likely objections in key jurisdictions, and including both independent and dependent claims in formats acceptable across the US, EPO, and IPO. One widely used approach is to draft the specification in a European style – expansive but without vague omnibus terms – and then present claims in both US and European formats, which satisfies the stricter European disclosure standards while still providing the breadth preferred by US practitioners.

Key differences at a glance 🔗

The table below highlights the core divergences a drafter must navigate.

India (Section 10, Patents Act 1970): Full and particular description, best mode disclosure, clear and succinct claims fairly based on the description, abstract within 150 words, and drawings per Rule 15. Biological material must be deposited with an approved authority.

EPO (Articles 83 and 84, Rule 42 EPC): Sufficiency of disclosure over the entire claim scope as of the filing date; claims must track description literally; actual experimental data strongly preferred; prophetic examples viewed negatively; no incorporation by reference from other applications.

USPTO (35 U.S.C. § 112): Separate written description and enablement requirements; prophetic examples accepted; incorporation by reference permitted; background section not mandatory; expansive claim language (e.g., “about”) acceptable.

PCT (WIPO Rules): Structured description under standard headings; single filing with deferred national examination; must be robust enough to satisfy each designated jurisdiction’s requirements on national phase entry.

Practical drafting strategy for Indian applicants 🔗

For Indian inventors and companies seeking global protection, a well-planned PCT application is often the most cost-effective entry point. The drafting should start with a disclosure standard that satisfies the most demanding jurisdiction in the target portfolio – typically the EPO. This means providing actual experimental data or at least detailed theoretical support, structuring the description with a clear technical problem-and-solution framework, and avoiding indefinite claim language. At the same time, the claims should include a range of independent and dependent claims flexible enough to support US continuation practice and the multi-claim formats permitted before the IPO.

When entering the Indian national phase under the PCT, the specification must be filed in English (or with a verified English translation if originally filed in another language), and the applicant must submit details of all corresponding applications filed outside India under Section 8(1) of the Patents Act. No amendments to the claims or specification text are permitted at the time of national phase entry beyond those already publicly available on the WIPO record.

The fundamental lesson is this: a specification drafted narrowly for one jurisdiction will almost certainly need costly amendments – or may not be salvageable at all – when entering other markets. The smarter approach is to invest in comprehensive, jurisdiction-aware drafting at the outset.

What do you think? Given that the EPO requires actual experimental data while the USPTO accepts prophetic examples, how should an Indian startup with limited resources prioritise its specification drafting when targeting both markets simultaneously? And considering that PCT applications must satisfy the strictest standards across all target jurisdictions, do you think a single unified specification format can ever fully replace jurisdiction-specific tailoring?

References

1. https://www.nortonrosefulbright.com/en/knowledge/publications/d4098ffa/global-patents-comparative-law-guide-sufficiency-of-disclosure
2. https://ipindia.gov.in/writereaddata/portal/ev/sections/ps10.html
3. https://thelegalschool.in/blog/section-10-indian-patent-act
4. https://acuraip.com/patent-specification-laws-in-india/
5. https://www.intepat.com/blog/definitiveness-in-indian-patent-law
6. https://www.intepat.com/blog/understanding-the-patent-specification-of-an-invention
7. https://en.wikipedia.org/wiki/Disclosure_of_the_invention_under_the_European_Patent_Convention
8. https://en.wikipedia.org/wiki/Claims_under_the_European_Patent_Convention
9. https://www.mcandrews-ip.com/sufficiency-disclosure-and-the/
10. https://www.uspto.gov/web/offices/pac/mpep/s1801.html
11. https://www.wipo.int/pct/en/faqs/faqs.html
12. https://www.intepat.com/blog/pct-patent-india
13. https://www.aipla.org/list/innovate-articles/entering-the-national-phase-of-patent-applications-in-india-under-the-patent-cooperation-treaty